Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 6/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.33 |
| ▸ | F2 | P00734 | 2/20 | 0.33 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5020478 | 0.92 | NPC1 (0.33) | HSP90AA1FFAR1KCNH2PPARGPPARA | |
| SCHEMBL5020447 | 0.88 | CCR1 (0.33) | HSP90AA1FFAR1KCNH2PPARGPPARA | |
| SCHEMBL15465206 | 0.88 | CCR1 (0.33) | HSP90AA1FFAR1KCNH2PPARGPPARA | |
| SCHEMBL10289683 | 0.86 | PPARG (0.32) | FFAR1KCNH2PPARGPPARA | |
| SCHEMBL5020233 | 0.86 | PPARG (0.31) | PPARGPPARA | |
| SCHEMBL5020230 | 0.85 | FFAR1 (0.31) | HSP90AA1FFAR1 | |
| SCHEMBL5020228 | 0.80 | FFAR1 (0.41) | FFAR1 | |
| SCHEMBL10289682 | 0.80 | KCNH2 (0.32) | HSP90AA1KCNH2PPARGPPARA | |
| SCHEMBL5020385 | 0.79 | CHRNB2 (0.34) | HSP90AA1KCNH2F2PPARGPPARA | |
| SCHEMBL5020359 | 0.79 | KCNH2 (0.36) | FFAR1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-02-13 | — | — | US | disclosed |
| US-20140045873-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2014-02-13 | — | — | US | disclosed |
| WO-2012062844-A1 | NOVEL MICROBIOCIDES | SYNGENTA PARTICIPATIONS AG (CH) | 2012-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140045873-A1 | NOVEL MICROBIOCIDES | MSR1, CD209, C3AR1 | HSP90AA1 1228/4885FFAR1 629/4885KCNH2 2388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.